183 related articles for article (PubMed ID: 19735729)
1. Direct binding of Grb2 SH3 domain to FGFR2 regulates SHP2 function.
Ahmed Z; George R; Lin CC; Suen KM; Levitt JA; Suhling K; Ladbury JE
Cell Signal; 2010 Jan; 22(1):23-33. PubMed ID: 19735729
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of the differential binding of the SH3 domains of Grb2 adaptor to the guanine nucleotide exchange factor Sos1.
McDonald CB; Seldeen KL; Deegan BJ; Farooq A
Arch Biochem Biophys; 2008 Nov; 479(1):52-62. PubMed ID: 18778683
[TBL] [Abstract][Full Text] [Related]
4. Coupling of the murine protein tyrosine phosphatase PEST to the epidermal growth factor (EGF) receptor through a Src homology 3 (SH3) domain-mediated association with Grb2.
Charest A; Wagner J; Kwan M; Tremblay ML
Oncogene; 1997 Apr; 14(14):1643-51. PubMed ID: 9135065
[TBL] [Abstract][Full Text] [Related]
5. Sprouty2 binds Grb2 at two different proline-rich regions, and the mechanism of ERK inhibition is independent of this interaction.
Martínez N; García-Domínguez CA; Domingo B; Oliva JL; Zarich N; Sánchez A; Gutiérrez-Eisman S; Llopis J; Rojas JM
Cell Signal; 2007 Nov; 19(11):2277-85. PubMed ID: 17689925
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of Grb2-Sos1 interaction: the N-terminal SH3 domain of Grb2 mediates affinity.
Sastry L; Lin W; Wong WT; Di Fiore PP; Scoppa CA; King CR
Oncogene; 1995 Sep; 11(6):1107-12. PubMed ID: 7566970
[TBL] [Abstract][Full Text] [Related]
7. Disabled-2 (Dab2) is an SH3 domain-binding partner of Grb2.
Xu XX; Yi T; Tang B; Lambeth JD
Oncogene; 1998 Mar; 16(12):1561-9. PubMed ID: 9569023
[TBL] [Abstract][Full Text] [Related]
8. Grb2 regulates Stat3 activation negatively in epidermal growth factor signalling.
Zhang T; Ma J; Cao X
Biochem J; 2003 Dec; 376(Pt 2):457-64. PubMed ID: 14498832
[TBL] [Abstract][Full Text] [Related]
9. Grb2 controls phosphorylation of FGFR2 by inhibiting receptor kinase and Shp2 phosphatase activity.
Ahmed Z; Lin CC; Suen KM; Melo FA; Levitt JA; Suhling K; Ladbury JE
J Cell Biol; 2013 Feb; 200(4):493-504. PubMed ID: 23420874
[TBL] [Abstract][Full Text] [Related]
10. The C-terminal SH3 domain of the adapter protein Grb2 binds with high affinity to sequences in Gab1 and SLP-76 which lack the SH3-typical P-x-x-P core motif.
Lewitzky M; Kardinal C; Gehring NH; Schmidt EK; Konkol B; Eulitz M; Birchmeier W; Schaeper U; Feller SM
Oncogene; 2001 Mar; 20(9):1052-62. PubMed ID: 11314042
[TBL] [Abstract][Full Text] [Related]
11. Tight association of GRB2 with receptor protein-tyrosine phosphatase alpha is mediated by the SH2 and C-terminal SH3 domains.
den Hertog J; Hunter T
EMBO J; 1996 Jun; 15(12):3016-27. PubMed ID: 8670803
[TBL] [Abstract][Full Text] [Related]
12. Tyrosine kinase signalling pathways.
Pawson T
Princess Takamatsu Symp; 1994; 24():303-22. PubMed ID: 8983084
[TBL] [Abstract][Full Text] [Related]
13. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
Vogel W; Ullrich A
Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
[TBL] [Abstract][Full Text] [Related]
14. The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1.
Rozakis-Adcock M; Fernley R; Wade J; Pawson T; Bowtell D
Nature; 1993 May; 363(6424):83-5. PubMed ID: 8479540
[TBL] [Abstract][Full Text] [Related]
15. UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.
Oneyama C; Nakano H; Sharma SV
Oncogene; 2002 Mar; 21(13):2037-50. PubMed ID: 11960376
[TBL] [Abstract][Full Text] [Related]
16. SH3-mediated targeting of Wrch1/RhoU by multiple adaptor proteins.
Risse SL; Vaz B; Burton MF; Aspenström P; Piekorz RP; Brunsveld L; Ahmadian MR
Biol Chem; 2013 Mar; 394(3):421-32. PubMed ID: 23183748
[TBL] [Abstract][Full Text] [Related]
17. MAP kinase phosphorylation of mSos1 promotes dissociation of mSos1-Shc and mSos1-EGF receptor complexes.
Rozakis-Adcock M; van der Geer P; Mbamalu G; Pawson T
Oncogene; 1995 Oct; 11(7):1417-26. PubMed ID: 7478566
[TBL] [Abstract][Full Text] [Related]
18. A Grb2-associated docking protein in EGF- and insulin-receptor signalling.
Holgado-Madruga M; Emlet DR; Moscatello DK; Godwin AK; Wong AJ
Nature; 1996 Feb; 379(6565):560-4. PubMed ID: 8596638
[TBL] [Abstract][Full Text] [Related]
19. Sprouty1 and Sprouty2 provide a control mechanism for the Ras/MAPK signalling pathway.
Hanafusa H; Torii S; Yasunaga T; Nishida E
Nat Cell Biol; 2002 Nov; 4(11):850-8. PubMed ID: 12402043
[TBL] [Abstract][Full Text] [Related]
20. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
